Vivian S. Lee, M.D., Ph.D., M.B.A, is President of Health Platforms at Verily Life Sciences, an Alphabet company whose mission is to apply digital solutions that enable people enjoy healthier lives. A passionate champion of improving health in the U.S. and worldwide, she works closely with Verily’s clinical and engineering teams to develop products and platforms that support the successful transformation of health systems to value and advance the co-production of health with patients, their caregivers, and communities. Among her roles as a founding leader of Verily Health Platforms is chairing the boards of Onduo, a virtual care digital health platform and Granular, an innovative stop-loss insurance company. She also leads the company’s COVID-19 employer and university product, Healthy at Work (and Healthy at School).
Dr Lee also serves as a Senior Lecturer at Harvard Medical School and Massachusetts General Hospital, and a Senior Fellow at the Institute for Healthcare Improvement. In 2019, she was ranked #11 among the Most Influential People in Healthcare (Modern Healthcare).
She is the author of the acclaimed book, The Long Fix: Solving America’s Health Care Crisis with Strategies that Work for Everyone (Norton, 2020).
Lee is an MR radiologist who developed novel methods for measuring kidney function and vascular disease with MRI. Funded by the NIH for 20 years, Dr Lee was elected to National Academy of Medicine in 2015, and in 2019, she received the International Society for Magnetic Resonance in Medicine’s highest award for scientific contributions and leadership, the Gold Medal. She served on the NIH Council of Councils advisory to the NIH Director and has authored over 200 peer-reviewed research publications. Presently she serves on the board of trustees for Boston Children’s Hospital, the Board of Directors of the Commonwealth Fund and the Association of American Rhodes Scholars, the Membership Committee of the National Academy of Medicine, and on the Scientific Advisory Board of the Massachusetts General Hospital. She is also a director on the board of Zions Bancorporation, a publicly traded company.
Dr Lee is a magna cum laude graduate of Harvard-Radcliffe Colleges, received a doctorate in medical engineering from Oxford University as a Rhodes Scholar, earned her M.D. with honours from Harvard Medical School, and was valedictorian of her Executive MBA program at NYU’s Stern School of Business.
